BioCentury
ARTICLE | Company News

Galen deal

January 14, 2002 8:00 AM UTC

GAL sold its Chemical Synthesis Services custom research business for£25 million ($36 million) in cash in a management buyout. The buyout team included Allen McClay, founder and former president of GA...